How a non-invasive, painless scan is transforming the way liver health is assessed — and why it matters for you.
GHC Hospitals, Thane • Gastroenterology & Hepatology • 5 April 2026
The liver is one of the most vital organs in the human body — responsible for filtering blood, removing toxins, metabolising drugs, and supporting digestion. When the liver is damaged or injured, the body’s ability to perform these essential functions diminishes, and a person with severely injured liver tissue can become progressively and seriously unwell.
Traditionally, assessing liver health required invasive procedures such as liver biopsy — carrying inherent risks, patient discomfort, and lengthy recovery. In recent years, a groundbreaking technology called FibroScan® has transformed the field of hepatology, offering a safer, faster, and more patient-friendly method of evaluating liver health. At GHC Hospitals, this technology is available as part of our comprehensive liver health services.
Liver biopsy vs. FibroScan® — what’s the difference?
Until recently, the only way doctors could inspect a patient’s liver in detail was through a liver biopsy — a procedure in which a small portion of liver tissue is surgically removed and examined in a laboratory. While effective, biopsies are expensive, invasive, and carry a risk of complications.
FibroScan®, based on ultrasound elastography technology, offers a compelling alternative. A small handheld probe is placed against the lower right section of the patient’s ribcage. The probe emits a shear wave into the body, which reflects off the liver tissue. The machine records and analyses these reflections, calculating the amounts of scar tissue and fat present — and displaying results instantly on screen.
Liver biopsy
- Invasive needle procedure
- Risk of bleeding and infection
- Requires anesthesia
- Results take days
- Hospital stay required
- Higher cost overall
FibroScan®
- Completely non-invasive
- No incisions or needles
- No anesthesia needed
- Results available instantly
- Outpatient — go home same day
- More cost-effective
FibroScan® drastically increases the feasibility of liver monitoring for at-risk patients. Many specialists believe it will increase the number of early diagnoses — allowing patients to begin treatment before serious complications develop.
Applications of FibroScan®
FibroScan® has become invaluable in diagnosing and monitoring a range of liver conditions. At GHC Hospitals, it is used across several clinical contexts:
Liver fibrosis assessment
Measures liver stiffness to detect and stage fibrosis — from early scarring to advanced cirrhosis.
Fatty liver detection
Assesses fat accumulation in liver cells (steatosis), helping identify NAFLD and alcohol-related liver changes.
Disease monitoring
Tracks progression of hepatitis, alcoholic liver disease, NAFLD, and cirrhosis over time.
Treatment evaluation
Helps assess whether current treatment is improving or stabilising liver stiffness and fat levels.
How FibroScan® measures fibrosis
FibroScan® uses transient elastography to measure the stiffness of liver tissue. The stiffer the tissue, the more likely fibrosis is present. Results are expressed as a numerical liver stiffness measurement (LSM) in kilopascals (kPa), which clinicians use to grade fibrosis severity.
How FibroScan® detects fatty liver
In addition to fibrosis, FibroScan® measures the liver’s attenuation coefficient (CAP), which indicates the presence and extent of fat accumulation. This enables clinicians to detect and grade steatosis without any invasive testing.
Benefits of FibroScan® at GHC Hospitals
- 1Non-invasive and painless. No needles, no incisions — the entire procedure involves only a handheld probe placed against the skin.
- 2Fast results. The scan takes only a few minutes, and results are available immediately — unlike biopsies, which can take several days to process.
- 3Safe and comfortable. No anesthesia or sedation is required. Patients experience minimal or no discomfort, and can return home immediately after.
- 4Suitable for a wide range of patients. Including older adults, those with co-existing conditions, and even paediatric patients — groups for whom biopsies may be particularly challenging.
- 5Repeatable over time. FibroScan® can be performed at regular intervals to monitor disease progression or track the response to treatment without repeated procedural risk.
- 6Cost-effective. By eliminating the need for hospitalisation, anesthesia, and surgical costs, FibroScan® significantly reduces the overall expense of liver monitoring.
How to prepare for a FibroScan®
Preparing for a FibroScan® is straightforward. Here is what patients at GHC Hospitals should keep in mind before their appointment:
Clothing
Wear loose, comfortable clothing. The upper right abdomen needs to be accessible for the probe.
Medications
Inform your doctor of all medications, including supplements — some can affect liver stiffness readings.
Food and drink
A light meal a few hours before is fine. Avoid heavy or fatty meals immediately before the scan.
Pregnancy / implants
Inform the technician if you are pregnant or have metallic implants such as a pacemaker.
The scan itself typically takes only a few minutes to complete. There is no recovery period, and patients leave the clinic immediately after.
Understanding your FibroScan® results
FibroScan® produces two key measurements:
Liver Stiffness Measurement (LSM) — expressed in kPa. Higher values indicate greater stiffness and more likely fibrosis. Results are staged from F0 to F4:
| Stage | Description | Clinical meaning |
|---|---|---|
| F0 | No fibrosis | Liver tissue is healthy and normal |
| F1 | Mild fibrosis | Early scarring; often manageable with lifestyle changes |
| F2 | Moderate fibrosis | Significant scarring; medical intervention recommended |
| F3 | Severe fibrosis | Advanced scarring; close monitoring required |
| F4 | Cirrhosis | Extensive scarring; specialist care essential |
Attenuation Coefficient (CAP) — measured in dB/m and used to grade fat content:
- S0CAP below 248 dB/m — no or minimal fat in the liver
- S1CAP 248–268 dB/m — moderate steatosis
- S2CAP above 268 dB/m — severe steatosis
FibroScan® results are always interpreted by our specialists in the context of your full clinical history. Several factors — including recent meals, alcohol intake, obesity, and certain medical conditions — can influence readings, and our team accounts for these during assessment.
Factors that can affect FibroScan® accuracy
It is important to be aware that certain conditions may influence the reliability of FibroScan® readings. These include recent food or alcohol consumption before the scan, active liver inflammation or acute injury, significant obesity, the presence of ascites (fluid accumulation in the abdomen), narrow intercostal spaces, metallic implants, and individual anatomical differences. Our hepatology team at GHC Hospitals takes all of these factors into consideration when interpreting results and making clinical recommendations.
What happens after your FibroScan® at GHC Hospitals?
Following the scan, our specialists will schedule a consultation to review your results in detail. Depending on findings, recommendations may include dietary changes, an exercise plan, medication adjustments, or a structured follow-up schedule for ongoing liver monitoring. If fibrosis or steatosis is detected, a monitoring plan will be established to track any changes over time and assess the effectiveness of any interventions.
At GHC Hospitals, we believe that informed patients make better health decisions. Our team is always available to answer your questions and guide you through every step of your liver health journey.
GHC Hospitals — Super Speciality Center
Thane Shil Road, Thane 400612
Appointments: 8976709204 | Emergency: 022-31007555 | ghchospitals.com